Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Go back to Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
(NASDAQ: ACXP) Delayed: 1.51 -0.03 (1.95%)
Previous Close $1.54    52 Week High
Open $1.59    52 Week Low
Day High $1.59    P/E N/A 
Day Low $1.51    EPS
Volume 62,974